B. The levels of CCL20 and IL-17A in sera from CRC patients, lung adenocarcinoma [LUAD] patients, glioblastoma [GBM] patients and controls (Healthy donors [HD]) were tested by Elisa (*P < 0.05; **P < 0.01; ***P < 0.001). Here, CCL20 is linked to glioblastoma.